Programmed Death (PD)-1-Deficient Mice Are Extremely Sensitive to Murine Hepatitis Virus Strain-3 (MHV-3) Infection
The inhibitory receptor programmed death-1 (PD-1) has the capacity to maintain peripheral tolerance and limit immunopathological damage; however, its precise role in fulminant viral hepatitis (FH) has yet to be described. Here, we investigated the functional mechanisms of PD-1 as related to FH pathogenesis induced by the murine hepatitis virus strain-3 (MHV-3). High levels of PD-1-positive CD4+, CD8+ T cells, NK cells and macrophages were observed in liver, spleen, lymph node and thymus tissues following MHV-3 infection. PD-1-deficient mice exhibited significantly higher expression of the effector molecule which initiates fibrinogen deposition, fibrinogen-like protein 2 (FGL2), than did their wild-type (WT) littermates. As a result, more severe tissue damage was produced and mortality rates were higher. Fluorescence double-staining revealed that FGL2 and PD-1 were not co-expressed on the same cells, while quantitative RT-PCR demonstrated that higher levels of IFN-γ and TNF-α mRNA transcription occurred in PD-1-deficient mice in response to MHV-3 infection. Conversely, in vivo blockade of IFN-γ and TNF-α led to efficient inhibition of FGL2 expression, greatly attenuated the development of tissue lesions, and ultimately reduced mortality. Thus, the up-regulation of FGL2 in PD-1-deficient mice was determined to be mediated by IFN-γ and TNF-α. Taken together, our results suggest that PD-1 signaling plays an essential role in decreasing the immunopathological damage induced by MHV-3 and that manipulation of this signal might be a useful strategy for FH immunotherapy.
Vyšlo v časopise:
Programmed Death (PD)-1-Deficient Mice Are Extremely Sensitive to Murine Hepatitis Virus Strain-3 (MHV-3) Infection. PLoS Pathog 7(7): e32767. doi:10.1371/journal.ppat.1001347
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001347
Souhrn
The inhibitory receptor programmed death-1 (PD-1) has the capacity to maintain peripheral tolerance and limit immunopathological damage; however, its precise role in fulminant viral hepatitis (FH) has yet to be described. Here, we investigated the functional mechanisms of PD-1 as related to FH pathogenesis induced by the murine hepatitis virus strain-3 (MHV-3). High levels of PD-1-positive CD4+, CD8+ T cells, NK cells and macrophages were observed in liver, spleen, lymph node and thymus tissues following MHV-3 infection. PD-1-deficient mice exhibited significantly higher expression of the effector molecule which initiates fibrinogen deposition, fibrinogen-like protein 2 (FGL2), than did their wild-type (WT) littermates. As a result, more severe tissue damage was produced and mortality rates were higher. Fluorescence double-staining revealed that FGL2 and PD-1 were not co-expressed on the same cells, while quantitative RT-PCR demonstrated that higher levels of IFN-γ and TNF-α mRNA transcription occurred in PD-1-deficient mice in response to MHV-3 infection. Conversely, in vivo blockade of IFN-γ and TNF-α led to efficient inhibition of FGL2 expression, greatly attenuated the development of tissue lesions, and ultimately reduced mortality. Thus, the up-regulation of FGL2 in PD-1-deficient mice was determined to be mediated by IFN-γ and TNF-α. Taken together, our results suggest that PD-1 signaling plays an essential role in decreasing the immunopathological damage induced by MHV-3 and that manipulation of this signal might be a useful strategy for FH immunotherapy.
Zdroje
1. RosenHR
MartinP
2000 Viral hepatitis in the liver transplant recipient. Infect Dis Clin North Am 14 761 784
2. PopeM
RotsteinO
ColeE
SinclairS
ParrR
1995 Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication. J Virol 69 5252 60
3. LevyGA
LeibowitzJL
EdgingtonTS
1981 Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice. J Exp Med 154 1150 63
4. LucchiariMA
MartinJP
ModollelM
PereiraCA
1991 Acquired immunity of A/J mice to mouse hepatitis virus 3 infection: dependence on interferon gamma synthesis and macrophage sensitivity to interferon gamma. J Gen Virol 72 1317 1322
5. MarsdenPA
NingQ
FungLS
LuoX
ChenY
2003 The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest 112 58 66
6. KeirME
ButteMJ
FreemanGJ
SharpeAH
2008 PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26 677 704
7. SheppardKA
FitzLJ
LeeJM
BenanderC
GeorgeJA
2004 PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta. FEBS Lett 574 37 41
8. ChemnitzJM
ParryRV
NicholsKE
JuneCH
RileyJL
2004 SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol 173 945 54
9. IwaiY
TerawakiS
IkegawaM
OkazakiT
HonjoT
2003 PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med 198 39 50
10. JunH
SeoSK
JeongHY
SeoHM
ZhuG
2005 B7-H1 (CD274) inhibits the development of herpetic stromal keratitis (HSK). FEBS Lett 579 6259 64
11. BarberDL
WherryEJ
MasopustD
ZhuB
AllisonJP
2006 Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439 682 87
12. VeluV
TitanjiK
ZhuB
HusainS
PladevegaA
2009 Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 458 206 10
13. TrautmannL
JanbazianL
ChomontN
SaidEA
GimmigS
2006 Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 12 1198 202
14. PennaA
PilliM
ZerbiniA
OrlandiniA
MezzadriS
2007 Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 45 588 601
15. SaidEA
DupuyFP
TrautmannL
ZhangY
ShiY
2010 Programmed death-1-induced interleukin-10 production by monocytes impairs CD4(+) T cell activation during HIV infection. Nat Med 16 452 9
16. DasS
SuarezG
BeswickEJ
SierraJC
GrahamDY
2006 Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. J Immunol 176 3000 9
17. SmithP
WalshCM
ManganNE
FallonRE
SayersJR
2004 Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand on macrophages. J Immunol 173 1240 48
18. Lázár-MolnárE
GácserA
FreemanGJ
AlmoSC
NathensonSG
2008 The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum. Proc Natl Acad Sci U S A 105 2658 63
19. TerrazasLI
MonteroD
TerrazasCA
ReyesJL
Rodriguez-SosaM
2005 Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis. Int J Parasitol 35 1349 58
20. MartinicMM
von HerrathMG
2008 Novel strategies to eliminate persistent viral infections. Trends Immunol 29 116 24
21. LiuM
MendicinoM
NingQ
GhanekarA
HeW
2006 Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: the role of Sp1/Sp3 and STAT1/PU.1 composite cis elements. J Immunol 176 7028 38
22. HancockWW
SzabaFM
BerggrenKN
ParentMA
MullarkyIK
2004 Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2. Proc Natl Acad Sci U S A 101 3005 10
23. BrownKE
FreemanGJ
WherryEJ
SharpeAH
2010 Role of PD-1 in regulating acute infections. Curr Opinion Immunol 22 397 401
24. HuangX
VenetF
WangYL
LepapeA
YuanZ
2009 PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci USA 106 6303 6308
25. FuseS
TsaiCY
MolloyMJ
AllieSR
ZhangW
2009 Recall responses by helpless memory CD8+ T cells are restricted by the upregulation of PD-1. J Immunol 182 4244 4254
26. YaoS
WangS
ZhuY
LuoL
ZhuG
2009 PD-1 on dendritic cells impedes innate immunity against bacterial infection. Blood 113 5811 5818
27. DickGA
NivenJF
GledhillAN
1956 A virus related to that causing hepatitis in mice (MHV). Br J Exp Pathol 37 90 98
28. DingJW
NingQ
LiuMF
LaiA
PeltekianK
1998 Expression of the fgl2 and its protein product (prothrombinase) in tissues during murine hepatitis virus strain-3 (MHV-3) infection. Adv Exp Med Biol 440 609 18
29. DingJW
NingQ
LiuMF
LaiA
LeibowitzJ
1997 Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase. J Virol 71 9223 30
30. ShalevI
WongKM
FoersterK
ZhuY
ChanC
2009 The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis. Hepatology 49 387 97
31. MarazziS
BlumS
HartmannR
GundersenD
SchreyerM
1998 Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes. J Immunol 161 138 47
32. ShalevI
LiuH
KoscikC
BartczakA
JavadiM
2008 Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis. J Immunol 180 249 60
33. FranceschiniD
ParoliM
FrancavillaV
VidettaM
MorroneS
2009 PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J Clin Invest 119 551 64
34. FranciscoLM
SalinasVH
BrownKE
VanguriVK
FreemanGJ
2009 PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 206 3015 29
35. LivakKJ
SchmittgenTD
2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 402 8
36. ChenY
ZhangJ
LiJ
ZhaoT
ZouL
2006 Triptolide inhibits B7-H1 expression on proinflammatory factor activated renal tubular epithelial cells by decreasing NF-kappaB transcription. Mol Immunol 43 1088 98
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 7
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Requires Glycerol for Maximum Fitness During The Tick Phase of the Enzootic Cycle
- Comparative Genomics Yields Insights into Niche Adaptation of Plant Vascular Wilt Pathogens
- The Role of IL-15 Deficiency in the Pathogenesis of Virus-Induced Asthma Exacerbations
- “Persisters”: Survival at the Cellular Level